Ipilimumab vs Telmisartan

## Ipilimumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Telmisartan**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Telmisartan**: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Telmisartan — 24 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Telmisartan — C33H30N4O2.

**Molecular Weight**: Ipilimumab — N/A; Telmisartan — 514.6230 g/mol.

**Type**: Ipilimumab — Antibody; Telmisartan — Small molecule.